Notify me when Foster James Alexander Cunliffe files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VRAX | Virax Biolabs Group Limited | Ordinary Shares | 8.3% | $232,199 | +$30,634 | 368,570 | +15% | James Foster | 31 Mar 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|